• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

最近关于 HSP90 抑制剂作为衰老细胞溶解剂的发现和开发的最新进展。

Recent update on discovery and development of Hsp90 inhibitors as senolytic agents.

机构信息

Natural Products Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung Institute of Natural Products, (25451) 679, Saimdang-ro, Gangneung-si, Gangwon-do, Republic of Korea.

Natural Products Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung Institute of Natural Products, (25451) 679, Saimdang-ro, Gangneung-si, Gangwon-do, Republic of Korea.

出版信息

Int J Biol Macromol. 2020 Oct 15;161:1086-1098. doi: 10.1016/j.ijbiomac.2020.06.115. Epub 2020 Jun 16.

DOI:10.1016/j.ijbiomac.2020.06.115
PMID:32561284
Abstract

Hsp90 chaperone is an encouraging target for the development of novel anticancer agents. The failure of Hsp90 inhibitors to get regulatory approval for the treatment of cancer is hindered due to toxicity, cost involved in their development and formulation issues. The inhibitors against this chaperone are also being evaluated in pre-clinical models for the treatment of diseases other than cancer (Alzheimer, malaria, AIDS, etc.). Recently, Hsp90 inhibitors have shown promising senolytic effect that is helpful in increasing the health and life span of mice. The senolytic property of Hsp90 inhibitors will make them less toxic for use in humans. The review focuses on Hsp90 inhibitors discovered till date as senolytic agents along with their future prospects. Further, the various models used for the evaluation of senolytic effect are also discussed.

摘要

Hsp90 伴侣蛋白是开发新型抗癌药物的一个有希望的靶点。由于毒性、开发和制剂成本问题,Hsp90 抑制剂未能获得监管部门批准用于癌症治疗。针对这种伴侣蛋白的抑制剂也正在临床前模型中评估用于治疗癌症以外的疾病(阿尔茨海默病、疟疾、艾滋病等)。最近,Hsp90 抑制剂已显示出有希望的衰老细胞选择性杀伤作用,有助于提高小鼠的健康和寿命。Hsp90 抑制剂的衰老细胞选择性杀伤作用将降低其对人类使用的毒性。本综述重点介绍了迄今为止发现的作为衰老细胞选择性杀伤剂的 Hsp90 抑制剂及其未来前景。此外,还讨论了用于评估衰老细胞选择性杀伤作用的各种模型。

相似文献

1
Recent update on discovery and development of Hsp90 inhibitors as senolytic agents.最近关于 HSP90 抑制剂作为衰老细胞溶解剂的发现和开发的最新进展。
Int J Biol Macromol. 2020 Oct 15;161:1086-1098. doi: 10.1016/j.ijbiomac.2020.06.115. Epub 2020 Jun 16.
2
Recent Advances in the Discovery of Novel HSP90 Inhibitors: An Update from 2014.从 2014 年起对新型 HSP90 抑制剂研发的最新进展综述
Curr Drug Targets. 2020;21(3):302-317. doi: 10.2174/1389450120666190829162544.
3
Identification of HSP90 inhibitors as a novel class of senolytics.鉴定热休克蛋白90(HSP90)抑制剂作为一类新型衰老细胞裂解剂。
Nat Commun. 2017 Sep 4;8(1):422. doi: 10.1038/s41467-017-00314-z.
4
Inhibiting protein-protein interactions of Hsp90 as a novel approach for targeting cancer.抑制热休克蛋白 90 的蛋白-蛋白相互作用作为一种针对癌症的新方法。
Eur J Med Chem. 2019 Sep 15;178:48-63. doi: 10.1016/j.ejmech.2019.05.073. Epub 2019 May 30.
5
Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.热休克蛋白90(Hsp90)作为药物研发的抗癌靶点:全面的计算视角
Chem Biol Drug Des. 2015 Nov;86(5):1131-60. doi: 10.1111/cbdd.12582. Epub 2015 Jun 11.
6
Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex.通过对热休克蛋白90(Hsp90)伴侣复合物的功能抑制,药物介导的多种蛋白质活性的靶向破坏。
Curr Med Chem. 2007;14(29):3122-38. doi: 10.2174/092986707782793925.
7
Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design.通过片段组合方法、虚拟筛选和基于结构的药物设计来产生热休克蛋白 90 抑制剂。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5778-83. doi: 10.1016/j.bmcl.2011.08.001. Epub 2011 Aug 6.
8
Heat shock protein 90 inhibitors as therapeutic agents.热休克蛋白 90 抑制剂作为治疗药物。
Recent Pat Anticancer Drug Discov. 2012 Sep;7(3):313-36. doi: 10.2174/157489212801820066.
9
Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions.靶向分子伴侣热休克蛋白 90(HSP90):经验教训与未来方向。
Cancer Treat Rev. 2013 Jun;39(4):375-87. doi: 10.1016/j.ctrv.2012.10.001. Epub 2012 Nov 28.
10
An updated patent review of anticancer Hsp90 inhibitors (2013-present).抗肿瘤 HSP90 抑制剂的最新专利审查(2013 年至今)。
Expert Opin Ther Pat. 2021 Jan;31(1):67-80. doi: 10.1080/13543776.2021.1829595. Epub 2020 Oct 5.

引用本文的文献

1
Senotherapy for chronic lung disease.慢性肺病的衰老细胞疗法
Pharmacol Rev. 2025 May 28;77(4):100069. doi: 10.1016/j.pharmr.2025.100069.
2
Functional Features of Senescent Cells and Implications for Therapy.衰老细胞的功能特征及其治疗意义。
Int J Mol Sci. 2025 Jun 4;26(11):5390. doi: 10.3390/ijms26115390.
3
A Xanthine Derivative With Novel Heat Shock Protein 90-Alpha Inhibitory and Senolytic Properties.一种具有新型热休克蛋白90-α抑制和衰老细胞溶解特性的黄嘌呤衍生物。
Aging Cell. 2025 Jul;24(7):e70047. doi: 10.1111/acel.70047. Epub 2025 Mar 17.
4
Chaperones as Potential Pharmacological Targets for Treating Protein Aggregation Illness.伴侣蛋白作为治疗蛋白质聚集疾病的潜在药理学靶点
Curr Protein Pept Sci. 2025 Jan 27. doi: 10.2174/0113892037338028241230092414.
5
Emerging roles of senolytics/senomorphics in HIV-related co-morbidities.衰老细胞清除剂/模拟物在与 HIV 相关的合并症中的新作用。
Biochem Pharmacol. 2024 Oct;228:116179. doi: 10.1016/j.bcp.2024.116179. Epub 2024 Mar 29.
6
Mechanisms and therapeutic strategies for senescence-associated secretory phenotype in the intervertebral disc degeneration microenvironment.椎间盘退变微环境中衰老相关分泌表型的机制及治疗策略
J Orthop Translat. 2024 Mar 12;45:56-65. doi: 10.1016/j.jot.2024.02.003. eCollection 2024 Mar.
7
Intervention treatment reducing cellular senescence inhibits tubulointerstitial fibrosis in diabetic mice following acute kidney injury.干预治疗减少细胞衰老可抑制急性肾损伤后糖尿病小鼠的肾小管间质纤维化。
Clin Sci (Lond). 2024 Mar 6;138(5):309-326. doi: 10.1042/CS20231698.
8
Heat shock protein 90: biological functions, diseases, and therapeutic targets.热休克蛋白90:生物学功能、疾病及治疗靶点
MedComm (2020). 2024 Jan 25;5(2):e470. doi: 10.1002/mco2.470. eCollection 2024 Feb.
9
The Cross Talk between Cellular Senescence and Melanoma: From Molecular Pathogenesis to Target Therapies.细胞衰老与黑色素瘤之间的相互作用:从分子发病机制到靶向治疗
Cancers (Basel). 2023 May 6;15(9):2640. doi: 10.3390/cancers15092640.
10
Heterocyclic Compounds as Hsp90 Inhibitors: A Perspective on Anticancer Applications.作为Hsp90抑制剂的杂环化合物:抗癌应用前景
Pharmaceutics. 2022 Oct 18;14(10):2220. doi: 10.3390/pharmaceutics14102220.